Nemaura Medical Inc. (NMRD)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
+0.0002 (0.00%)
Dec 26, 2024, 3:00 PM EST
Nemaura Medical Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.14 | 10.11 | 17.75 | 31.87 | 0.11 | 3.74 | Upgrade
|
| Cash & Short-Term Investments | 0.14 | 10.11 | 17.75 | 31.87 | 0.11 | 3.74 | Upgrade
|
| Cash Growth | -98.13% | -43.07% | -44.30% | 29931.36% | -97.16% | -34.76% | Upgrade
|
| Accounts Receivable | - | - | 0.1 | - | - | - | Upgrade
|
| Other Receivables | 0.25 | 0.41 | 0.26 | 0.09 | - | 0.21 | Upgrade
|
| Receivables | 0.25 | 0.41 | 0.36 | 0.09 | - | 0.21 | Upgrade
|
| Inventory | 3.67 | 1.75 | 1.49 | 1.44 | 0.29 | 0.04 | Upgrade
|
| Prepaid Expenses | 0.17 | 0.36 | 0.5 | 0.59 | 0.45 | 0.53 | Upgrade
|
| Other Current Assets | 0.15 | 0.91 | - | - | - | - | Upgrade
|
| Total Current Assets | 4.37 | 13.54 | 20.09 | 33.99 | 0.84 | 4.52 | Upgrade
|
| Property, Plant & Equipment | 0.56 | 0.64 | 0.53 | 0.2 | 0.16 | 0.06 | Upgrade
|
| Other Intangible Assets | 0.24 | 0.38 | 1.48 | 1.06 | 0.21 | 0.19 | Upgrade
|
| Total Assets | 5.17 | 14.56 | 22.1 | 35.24 | 1.22 | 4.76 | Upgrade
|
| Accounts Payable | 0.35 | 0.33 | 0.14 | 0.25 | 0.29 | 0.16 | Upgrade
|
| Accrued Expenses | - | 0.13 | 0.56 | - | - | 0.11 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.08 | - | Upgrade
|
| Current Portion of Long-Term Debt | 19.64 | 16.94 | 19.19 | 5.73 | - | - | Upgrade
|
| Current Unearned Revenue | 1.18 | 0.12 | 0.26 | 0.1 | 0.09 | 0.07 | Upgrade
|
| Other Current Liabilities | 1.82 | 4.74 | 0.44 | 0.33 | 0.92 | 0.96 | Upgrade
|
| Total Current Liabilities | 23 | 22.27 | 20.58 | 6.42 | 1.39 | 1.3 | Upgrade
|
| Long-Term Debt | - | 3.09 | - | 19.19 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | 1.02 | 1.05 | 1.28 | 1.15 | 1.24 | Upgrade
|
| Total Liabilities | 23 | 26.38 | 21.64 | 26.88 | 2.53 | 2.54 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 40.99 | 40.99 | 38.3 | 32.04 | 16.59 | 15.97 | Upgrade
|
| Retained Earnings | -57.84 | -51.88 | -37.73 | -23.84 | -17.59 | -13.43 | Upgrade
|
| Comprehensive Income & Other | -1 | -0.96 | -0.12 | 0.14 | -0.34 | -0.34 | Upgrade
|
| Total Common Equity | -17.83 | -11.81 | 0.47 | 8.36 | -1.31 | 2.23 | Upgrade
|
| Shareholders' Equity | -17.83 | -11.81 | 0.47 | 8.36 | -1.31 | 2.23 | Upgrade
|
| Total Liabilities & Equity | 5.17 | 14.56 | 22.1 | 35.24 | 1.22 | 4.76 | Upgrade
|
| Total Debt | 19.64 | 20.03 | 19.19 | 24.92 | 0.08 | - | Upgrade
|
| Net Cash (Debt) | -19.51 | -9.93 | -1.44 | 6.94 | 0.02 | 3.74 | Upgrade
|
| Net Cash Growth | - | - | - | 29380.63% | -99.37% | -34.76% | Upgrade
|
| Net Cash Per Share | -0.69 | -0.40 | -0.06 | 0.31 | 0.00 | 0.21 | Upgrade
|
| Filing Date Shares Outstanding | 28.9 | 28.9 | 24.1 | 23.31 | 20.96 | 20.8 | Upgrade
|
| Total Common Shares Outstanding | 28.9 | 28.9 | 24.1 | 22.94 | 20.85 | 20.77 | Upgrade
|
| Working Capital | -18.62 | -8.73 | -0.49 | 27.57 | -0.54 | 3.22 | Upgrade
|
| Book Value Per Share | -0.62 | -0.41 | 0.02 | 0.36 | -0.06 | 0.11 | Upgrade
|
| Tangible Book Value | -18.06 | -12.2 | -1.01 | 7.3 | -1.53 | 2.04 | Upgrade
|
| Tangible Book Value Per Share | -0.63 | -0.42 | -0.04 | 0.32 | -0.07 | 0.10 | Upgrade
|
| Machinery | - | 1.11 | 0.81 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.